Purchase Order 36C24824P1906

Award Date 7/9/24
Potential Completion Date 7/15/24
Potential Value $10K
Ultimate Awardee
Mckesson Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs to McKesson Corporation, a large healthcare services and IT company, for the delivery of HUMATIN USP CAPS 250MG 100 EMERGENCY pharmaceutical products. The $11,859 contract has a completion date of June 30, 2025 and does not utilize any set-aside designations. McKesson Corporation is the prime contractor, and the contract supports the Department of Veterans Affairs' healthcare programs and medical...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to McKesson Specialty Health Pharmaceutical & Biotech Solutions LLC, a subsidiary of McKesson Corporation. The contract is for the delivery of HUMATIN USP CAPS 250MG pharmaceutical products, with a ceiling value of $23,718.00 and an ultimate completion date of June 27, 2025. The contract was not set aside for any specific business type. McKesson Corporation is a large, for-profit...
This firm fixed-price purchase order for $10,312.20 was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 to Mckesson Corporation, a healthcare services and IT company, for the delivery of "EMERGENCY HUMATIN" by August 24, 2024. The contract does not have a set-aside designation. Mckesson is the prime contractor and does not have any major subcontractors identified. The VA has utilized Mckesson as a prime contractor through various...
This is a $10,312.20 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 20 to Mckesson Corporation, a healthcare services and IT company, for the provision of HUMATIN EMERGENT products. The contract has a completion date of July 10, 2024 and does not utilize a set-aside designation. This contract award appears to be part of Mckesson's broader work as a prime contractor providing pharmaceuticals, medical supplies, and healthcare IT...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 8 to the prime contractor Mckesson Corporation, doing business as Mckesson, to provide Paromomycin 250mg HUMATIN pharmaceuticals. The contract has a ceiling value of $10,312.20 and a completion date of September 27, 2024. Mckesson is a healthcare services and information technology company that provides pharmaceuticals, medical supplies, and healthcare IT solutions...
The Department of Veterans Affairs awarded a firm fixed price purchase order to Mckesson Corporation, doing business as Mckesson, for the supply of HUMATIN (PAROMOMYCIN) 250MG. The contract has a ceiling value of $11,859.00 and an ultimate completion date of January 13, 2025. This award was not set aside for any specific business type. Mckesson is a healthcare services and IT company that provides pharmaceuticals, medical supplies, and healthcare solutions to government agencies. The company has...
This federal contract award, valued at $20,624.40, was issued by the Department of Veterans Affairs (VA) to Mckesson Corporation, a healthcare services and IT company, for the provision of HUMATIN 250MG pharmaceuticals. The award is structured as a firm fixed price purchase order with a completion date of November 29, 2024. Mckesson, the prime contractor, has previously provided a range of pharmaceutical products and services to various federal agencies, including the Department of Justice's...
This is a firm fixed price delivery order awarded by the Department of Defense's Medical Supply Chain branch to prime contractor Mckesson Corporation, doing business as Mckesson Drug Company. The contract has a ceiling value of $160,123.60 and a completion date of January 5, 2017. Mckesson, a healthcare services and IT company, has provided over $5.8 million in pharmaceutical products such as penicillin injections and alvimopan capsules to the Department of Veterans Affairs' Veterans Health...
This is a firm fixed-price delivery order contract awarded by the Department of Defense's Medical Supply Chain branch to Mckesson Corporation, doing business as Mckesson Drug Company, with a ceiling value of $307,203.84 and an ultimate completion date of July 13, 2015. The contract is not associated with a set-aside program. Under this contract, Mckesson will provide pharmaceutical products such as penicillin injections and alvimopan capsules to the Department of Veterans Affairs' Veterans...
This is a firm fixed price delivery order contract awarded by the Department of Defense's Medical Supply Chain to the prime contractor Mckesson Corporation, doing business as Mckesson Drug Company. The contract has a ceiling value of $534,112.81 and an ultimate completion date of January 5, 2017. Mckesson, a for-profit healthcare services and IT company, has provided over $5.8 million in pharmaceutical products such as penicillin injections and alvimopan capsules to the Department of Veterans...

This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Mckesson Specialty Care Distribution LLC, a subsidiary of the Mckesson Corporation, to provide Emergency Humatin Capsules. The contract has a ceiling value of $10,312.20 and a completion date of July 15, 2024. Mckesson Specialty Care Distribution, as a major healthcare distributor, regularly partners with various VHA regional networks to fulfill pharmaceutical and medical supply requirements. This contract is part of Mckesson's broader role in maintaining supply chain continuity for critical drugs and medical products purchased through federal contracts to meet the healthcare needs of U.S. veterans. The contract does not have a set-aside designation.

Generated 7/11/24, 9:43 AM